Please assess the completion status of the following clinical trial:

Trial Title: Generalized Neonatal Screening of Severe Combined Immunodeficiencies

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Screening Group: Newborn on day 3 of birth (premature and non premature)~* Control group: Patients diagnosed with SCID without screening at participating centers~Exclusion Criteria:~* Lack of parental consent~* Children whose parents are adults under guardianship,~* Children without health insurance, for the screening group:~* The early exit of the child from the maternity hospital

- Gender: ALL
- Minimum Age: 3 Days
- Maximum Age: 18 Months
- Healthy Volunteers: t

Study Arms:
- Screened patients (Type: EXPERIMENTAL): SCID screening: more drops of blood are placed on a second Guthrie card when current screening (72 hours of life ) is performed after parents' information and consent. The card drawn for the protocol will follow the usual network except that the test for quantifying TRECs will be realized to determine the presence of SCID.
- Control group (Type: NO_INTERVENTION): SCID children diagnosed without screening by pediatricians local referents DIP

Based on this trial design, predict the completion outcome and termination type (if applicable).